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Abstract Latinos have lower rates for most common cancer
sites and higher rates of some less common cancers (gallblad-
der, liver, gastric, and cervical) than other ethnic/racial groups.
Latinos are a highly heterogeneous population with diverse
national origins, unique genetic admixture patterns, and wide
spectrum of socio-demographic characteristics. Across the
major cancers (breast, colorectal, prostate, lung, and liver)
US-born Latinos have higher incidence and worse survival
than foreign-born, and those with low-socioeconomic status
have the lowest incidence. Puerto Rican and Cuban Latinos
have higher incidence rates than Mexican Latinos. We have
identified the following themes as understudied and critical to
reduce the cancer burden among US Latinos: (1) etiological
studies considering key sources of heterogeneity, (2) cultural-
ly sensitive cancer prevention strategies, (3) description of the
molecular tumor landscape to guide treatments and improve
outcomes, and (4) development of prediction models of dis-
ease risk and outcomes accounting for heterogeneity of
Latinos.
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Introduction
Hispanics/Latinos (referred henceforth as Latinos) are the
largest and fastest growing minority group in the USA, and
with a population of over 55 million, they account for 17 % of
the US population in 2014 [1], which is predicted to increase
to 35% by the year 2050. Despite having higher poverty rates,
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lower education, and less access to health care than non-
Hispanic Whites (NHW), Latinos tend to have overall better
health indicators than those of other racial/ethnic groups with
whom they share socio-economic (SES) characteristics. This
epidemiologic phenomenon coined Bthe Hispanic paradox^
[2–5] might be explained by cultural and lifestyle practices
brought by Latino immigrants from their countries of origin,
reproductive behavior, extended family support, and a distinct
genetic heritage [3]. It has been proposed that these putative
health-relatedadvantages inLatino immigrantsmayerodeover
successive generations in the USAwith increased assimilation
[4].Overall, cancer incidence rates (breast, colorectal, lung, and
prostate) inUSLatinos tend tobehigher than those reported for
most Latin American countries [6•], although differences in
completeness of cancer registries between the USA and Latin
America cannot be discarded as a possible explanation.
Mortality rates also tend to be lower for Latinos compared to
NHW;however, there are substantial disparities in cancer prev-
alence, care, and outcomes that are still not understood.
Latinos are the result of more than 500 years of admix-
ture of European, Indigenous American (IA), and African
individuals, with varying degrees across Latin America
[7]. In the USA, the majority of Latinos are of Mexican
national origin (64.3 %), followed by Puerto Rican
(9.5 %), Salvadorean (3.7 %), Cuban (3.7 %), and
Dominican (3.1 %), with the rest coming from other
Central and South American countries [8]. Overall, about
60 % of these individuals are US-born, with the remaining
40 % born in Mexico (64 %), Puerto Rico (9 %), and other
Latin American countries. US Latinos include recent im-
migrants who make similar lifestyle and dietary choices as
those in their countries of origin, as well as second or
higher generation immigrants born in the USA who are
partially or fully assimilated to the US lifestyle. Both ge-
netic ancestry and nativity correlate with known cancer
determinants. For example, there are differences in trends
for body mass index (BMI) by nativity among US Latinos,
with US-born Mexican and Puerto Ricans having greater
annual increases in BMI than US-born Cubans and
foreign-borns [9]. Also, Latinos of higher IA or African
ancestry are more likely to have a lower SES than those
with higher European ancestry [10–12].
This heterogeneity presents a unique opportunity to
disentangle the complex role of SES, culture, lifestyle,
and genetics, as potential determinants of cancer risk in
Latinos and other populations. In spite of this rich diver-
sity, epidemiological studies have largely ignored it and
have grouped Latinos as a single ethnic group. A better
understanding of the heterogeneity that exists within
Latinos may give important clues regarding the key can-
cer determinants and cancer characteristics in this popula-
tion and help achieve the goal of personalized medicine in
this fast growing minority group.
Overall Cancer Risk Patterns Among Latinos
Overall, Latinos in the USA have lower incidence rates for the
most common cancer sites, namely breast, lung, colorectal,
and prostate cancer compared to NHW and African
Americans (AA). However, they have higher incidence rates
for cervical, penile, and some gastrointestinal cancers (gall-
bladder, gastric, and liver), which are typically associated with
low SES, obesity, and diabetes and many of them also with
infections (e.g., Human Papillomavirus, hepatitis B and C
viruses, and Helicobacter pylori). Additionally, compared to
NHW, and similarly to AA [6•], Latinos are more likely to be
diagnosed at an advanced stage of disease for most common
cancers and have higher mortality rates for select cancers such
as breast, gastrointestinal, uterine, and cervical, potentially
due to lower rates of access to care, limited proper screening,
lack of early detection, and/or biologic factors. An increasing
trend of early-onset disease (<50 years) among Latinos in the
last few decades has been reported [13–15, 16•, 17].
Importantly, these trends in incidence and mortality differ
widely among Latino subpopulations.
Variability in Cancer Determinants Among Latino
Subpopulations
As with other racial/ethnic populations in the USA, differ-
ences in cancer determinants across US Latinos are in part
due to substantial variation within this population in the prev-
alence of well-established cancer risk factors such as smoking,
low quality diet, and physical inactivity. In addition, limited
access to health care and financial constraints among US
Latinos has been associated with lower cancer screening rates
[18, 19]. Even though Latinos share a common language and
history, similarly to other migrant populations in the USA,
such as Asians, there is significant variability in cultural fac-
tors, which vary by countries of origin, nativity, and level of
assimilation to the USA lifestyle. For foreign-born Latinos,
there is also further variability in exposures acquired in their
countries of origin and the social class of origin. The degree to
which individuals have assimilated to the USA and their SES
strongly influence behavioral patterns related to cancer pre-
vention, diagnosis, and treatment [20, 21].
Unlike other populations, among Latinos, there is the
added variability introduced by their admixed genetic back-
ground. The proportion of any one of the three main ancestral
populations could affect the presence of cancer susceptibility
alleles and/or could be a proxy for other factors that might be
tightly correlated with ancestry, such as SES, culture (e.g.,
adherence to traditional values), and lifestyle. These factors
could jointly or independently determine cancer risk and sur-
vival. We summarize below the existing knowledge on cancer
trends, risk factors, clinical characteristics, and survival
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patterns among Latinos for selected cancers (breast, colorec-
tal, prostate, lung, and liver) for which there is available evi-
dence of disparities across subpopulations defined by nativity,




Breast cancer (BC) is the most common cancer in US Latinas,
with 19,800 women expected to be diagnosed in 2015 [1].
However, within Latinas, incidence varies substantially by
national origin [6•], place of birth (US-born vs. foreign-born)
and neighborhood context [22, 23]. In Florida, Puerto Rican
and Cuban Latinas have higher rates of BC than those from
Mexico and other Latin American countries combined, com-
parable to those in AA [6•]. Puerto Rican women living on the
island have been reported to have a significantly lower inci-
dence rate than those living in mainland USA [24], and
foreign-born Latinas in California have lower risk of develop-
ing BC than US-born [22], with increasing risk with longer
US residency [23]. The 2000 and 2005 National Health
Interview Survey (NHIS) Cancer Control Modules observed
a higher 5-year absolute risk in Cubans/Cuban Americans
compared to Mexican/Mexican Americans and a higher life-
time risk in Dominicans compared to Mexican/Mexican
Americans [25].
Studies focused on genetic ancestry reported that Latinas
with high IA ancestry have lower risk of developing BC than
those with high European ancestry, which was still observed
after controlling for most established risk factors that are
known to differ between Latina and NHW women [10, 26].
Moreover, Latina womenwho live within neighborhoods with
mostly Latinos and with high use of Spanish language
(BHispanic enclaves^) and with low SES have lower risk than
their counterparts [22]. The role of African ancestry in defin-
ing BC risk by Latina national origin has not been examined.
Risk Factors
Exposure to anthropometric, reproductive, behavioral, and ge-
netic factors differs between Latino subpopulations, which
might contribute to observed differences in incidence. For
example, Latinas with higher IA ancestry tend to have more
children than those with higher European ancestry [27]. BMI
is associated with genetic ancestry among Latinas, although
the direction of association is inconsistent between studies
from different US regions [27, 28], suggesting an additional
source of heterogeneity in subpopulation differences in BC-
related exposures. However, consideration of these factors still
shows an independent effect of IA ancestry on BC risk [10,
26], suggesting there are additional lifestyle or behavioral fac-
tors that correlate with IA ancestry yet to be discovered, and/or
genetic risk factors.
Multiple candidate gene studies have reported heterogene-
ity in associations by IA ancestry [29–32]. A GWAS study of
BC in Latinas found a protective variant near the ESR1 gene
that is only observed in women that have IA ancestry. The
frequency of the protective variant in women of different na-
tional origins correlates with the known average proportion of
IA ancestry for the region: It has a frequency of 5 % in Puerto
Ricans, 10 % in Colombians, 14 % in Mexicans, and 23 % in
Peruvians [33•]. This study also confirmed the association of
previously reported variants, with 84% of the polymorphisms
having odds ratios that were directionally concordant with
those reported in European and/or Asian studies [33•].
Clinical Characteristics and Survival
In California, Latinas living in low SES and high BHispanic
enclave^ neighborhoods were ∼24 % more likely to be diag-
nosed with more advanced stage than their counterparts [34].
Being foreign-born was an independent predictor of higher
stage at diagnosis; however, despite this, foreign-born
Latinas had marginally better survival than US-born Latinas,
independently of SES and neighborhood enclave, stage, and
treatment [34]. When considering genetic ancestry, California
Latinas with more than 50 % IA ancestry have approximately
twice the mortality hazard of women with 50 % or less [35],
and Caribbean women had a higher mortality hazard than
women from Central America, after controlling for genetic
ancestry, education, SES, tumor characteristics, and treatment
information [35]. Genetic ancestry was not found to be asso-
ciated with tumor characteristics (i.e., estrogen and progester-
one receptor status, stage and grade at diagnosis, and tumor




Colorectal cancer (CRC) is the second most common cancer
in both Latino men and women, with an estimated total of
11,700 new cases and 3800 deaths in 2015 [1]. CRC incidence
and death rates among Latinos are approximately 10 to 20 %
lower than those among NHWs. However, incidence rates for
CRC are higher among higher SES Latinos (68.1 per 100,000
for men and 43.4 per 100,000 for women) than among lower
SES Latinos (41.5 per 100,000 and 28.7 per 100,000 for wom-
en) [36]. This pattern is the opposite of what is observed for
NHW and AA. These data suggests that as Latinos acquire
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higher SES and assimilate to the US lifestyle, they may ac-
quire additional risk factors that increase their CRC risk.
CRC incidence rates also vary substantially across Latinos
by national origin. In Florida, CRC incidence rates among
Cuban and Puerto Rican men were reported to be similar to
those of NHW and twice those of Mexican men [6•].
Moreover, Mexican, Cuban, and Puerto Rican Latinos living
in Florida had higher incidence rates than those living in their
countries of origin or Puerto Rico [6•]. A separate study also
reported that Puerto Ricans living in the island were found to
have lower incidence rates than those living in various regions
of mainland USA [24]. In California, Cuban Latinos had
higher incidence than Mexican Latinos [37•]. In this same
study, proportional incidence ratios considering SES and na-
tivity showed that Cuban Latinos (both men and women) and
Puerto Rican Latinas had more cases than expected, whereas
Mexican Latinos had fewer cases than expected, confirming
possible differences by national origin [37•].
Notably, incidence rates are increasing among adults aged
younger than 50 years [14, 38]. In Puerto Rico, close to 10 %
of all CRC cases are younger than 50 and two thirds of cases
present at advanced stage. In response to this, the Puerto Rico
Department of Health issued guidelines in 2015 to begin
screening at age 40, and a national program using fecal im-
munological testing was established.
Risk Factors
High intake of red meat and processed meats, lack of dietary
fiber, alcohol intake, smoking, lack of physical activity, dia-
betes, family history of CRC, and obesity are known CRC risk
factors. In the Multiethnic Cohort Study (MEC), Latinos re-
ported a higher prevalence of obesity and diabetes, and lower
prevalence of family history of CRC, colorectal polyps, and
smoking, and higher consumption of dietary fiber, calcium,
and folate than NHW [39]. Heritability estimates for CRC are
approximately 12–35 %; however, highly penetrant, inherited
mutations account for less than 5 % of these cancers. GWAS
of CRC conducted mostly among NHW and Asians have
identified 58 susceptibility alleles across 37 regions [40]. A
study among Colombians reported a positive association be-
tween African ancestry and CRC risk [41]. In addition, the
only GWAS study in US-Latinos in California reported that
only a third of the known GWAS-identified risk loci in NHW
were nominally statistically significant among Latinos; impor-
tantly, secondary susceptibility variants at 3q26.2 and 11q12.2
were identified in this population [42].
Clinical Characteristics and Survival
Latinos tend to be diagnosed at a younger age and with higher
stage, and Mexican Latinos in California were reported to
have the greatest proportion compared to other Latino
subgroups [43]. Moreover, Mexican Latinos have higher pro-
portion of rectal cancer cases compared to other Latinos and
NHW [43]. Recent studies have suggested a lower incidence
of tumors with high microsatellite instability (MSI-High) and
hereditary CRC syndromes in Latinos as compared to NHW
[13, 44, 45], which is associated with better survival [46].
There is paucity of data on other tumor markers in Latinos,
as well as knowledge of genetic variants that can be used for
prognosis, all of which are critical for treatment decisions.
Latinos have improved survival rates compared to other
ethnic/racial groups. However, US Latinos living in neighbor-
hoods with more than 60% Latinos had a 14% greater chance
of being diagnosed with late versus early stage CRC than
Latinos living in neighborhoods with less than 20 % Latinos
[47]. Furthermore, Latinos that live in low SES neighbor-
hoods had lower survival than those living in high SES neigh-
borhoods [48]. This association was more pronounced among
US-born Latinos, who were found to have lower survival than
foreign-born Latinos [48]. A Bhealthy immigrant^ effect has
been proposed as an explanation, but it does not seem to
explain fully the observed disparities.
Prostate Cancer
Incidence
Prostate cancer (PC) incidence among Latino men is lower
than among NHW or AA men; however, PC is the number
one cancer that affects Latino men, with 13,000 men diag-
nosed in 2015 [1]. Mexican Latinos have been reported to
have a lower incidence than NHW, Cubans and Puerto
Rican Latinos [6•, 49, 50]. In contrast, Cuban and Puerto
Rican Latinos have comparable or slightly higher rates than
NHW [6•, 49, 50]. A study in Florida also reported that
Mexican, Puerto Rican, and Cuban US Latinos had higher
incidence rates than those reported in Mexico, Cuba, and
Puerto Rico [6•]. Moreover, Puerto Ricans living in the island
have lower cancer incidence rates than those living in various
regions of the mainland US [24] or US Latinos [51].
Latinos living in the highest SES category were report-
ed to have an incidence rate that was 78 % higher than
those living in the lowest SES category [36]. Whereas
similar disparities have been observed for NHW, AA,
and Asians, those observed for Latinos were considerably
greater. PSA testing is lower among Latinos compared to
other racial groups [52], and more commonly used among
higher SES men. However, differences in PSA use are
unlikely to explain fully the observed disparity by SES
as this disparity is also observed when restricting cases
to aggressive cancer, which are less likely to be detected
by PSA screening [49].
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Risk Factors
There are few established risk factors for prostate cancer
other than age, family history of PC and race/ethnicity,
and even fewer uniquely identified for Latinos. Several
common genetic variants have been identified through
GWAS studies that can increase the risk of PC among
NHW and AA men; many of these have been reported
to be associated with risk among Latinos [53]. A study
among Mexican Latinos in Texas identified associations
between exposure to agrichemicals, being US-born, lack
of physical activity and PC family history and higher risk
of PC [54]. This finding is supported by the observation
that California farm workers, which are predominantly
Mexican migrant workers, showed disproportionately
more PC cases than Californian NHW [55]. Diets high
in red meat have been proposed to increase PC risk, and
an association between red meat cooked at high tempera-
tures and risk was reported among Latinos in a multi-
ethnic study [56]. Interestingly, Latinos showed higher
prevalence of intake of red meat cooked using high tem-
perature methods, and whereas no associations were
found for specific meat mutagens and NHW and AA
men, significant positive associations were reported for
Latinos [56].
Clinical Characteristics and Survival
Unlike NHW and AA men, Latino men in Texas with higher
degree of SES deprivation have reduced mortality compared
to men with low deprivation [57]. Moreover, in California,
foreign-born Latino men were reported to be more likely to
be diagnosed with advanced disease than US-born men; how-
ever, those who resided in high Hispanic enclave neighbor-
hoods, in spite of the overall lower SES, had better survival
than US-born Latinos living in comparable neighborhoods
[58]. In contrast with these findings, mortality rates were re-
ported to be higher among Puerto Rican men living in the
island compared to mainland US Latinos [51].
Lung Cancer
Incidence
Lung cancer (LC) is the third-most commonly diagnosed can-
cer in Latino men and the fifth most common in Latinas.
Incidence rates (43.4 and 26 per 100,000 for men and women,
respectively) are lower than in NHW and AA, with 9600
Latinos expected to be diagnosed in 2015 [59•]. However,
differences in incidence have been reported by nativity.
Incidence rates are reported to be lowest among Mexican
Latinos, followed by Puerto Ricans and Cubans [50].
Moreover, Puerto Ricans living on the island have lower inci-
dence rates than Puerto Ricans living in Florida [6•, 24].
Similar to other cancers, and in complete contrast with
NHW, AA, and Asians, incidence rates for Latinos in
California were highest among high SES and lowest among
low SES [36].
Risk Factors
The observed heterogeneity in LC rates within the Latino
population may reflect differences in smoking patterns. The
overall percentage of smokers among Latino men and women
is lower than for NHWor AA [60, 61], with rates being higher
among US-born Latinos than among foreign-born, especially
among women. Cubans and Puerto Ricans are more likely to
smoke (18 %) than Mexicans (13 %), Central Americans, or
Dominicans [1, 60, 62, 63]. In addition, Latino smokers of all
national origins tend to smoke less intensively than NHW
with about 50 % smoking 5 or fewer cigarettes per day or
reporting non-daily smoking [64]. Interestingly, given similar
smoking intensity, Latinos in the MEC Study were shown to
have 30 to 70 % lower relative risk of developing LC than the
AA reference group until smoking intensity reached 30 ciga-
rettes per day [65]. Non-smoking Latinos have low levels of
second-hand smoke exposure overall, but Latinos tend to have
higher exposure at their worksite [66]. A study in New
Mexico reported that Latinos were more likely than NHW to
have a composite methylation index in sputum, reported to
associate with LC risk, and a more rapid increase in risk was
observed as a function of cigarette smoke [67•]. However,
among Latinos, higher IA ancestry was associated with lower
risk of detecting this methylation index [67•].
Clinical Characteristics and Survival
Among Latinos, LC is the leading cause of cancer death in
men (17 %) and the second leading cause of cancer death in
women (13 %) [59•]; however, the mortality rates are 50 %
those of NHW [1]. Among women, Cubans (13.4 %) and
Puerto Ricans (13.3 %) have a higher percentage of death
due to LC compared to other Latinas (11.9 %) [68]. Among
men, the proportion of cancer deaths were higher for Cuban
men (30.1 %) followed by Mexican (23.2 %) and Puerto
Rican (23.7 %) men [68]. Also, Latino men have a 5-year
survival rate of 15 %, which is lower than the 18 % reported
for NHW; whereas among women rates are comparable (23
vs. 24 %, NHWand Latinas, respectively). However, Latinos,
both US- and foreign-born, are reported to have improved
overall survival compared to NHW [69]. This overall survival
advantage of Latino patients with non-small cell lung cancer
(NSCLC) might be because of higher prevalence of histologic
subtypes (e.g., bronchioloalveolar carcinoma) of NSCLC as-
sociated with better prognosis [69]. Despite the fact that
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Latinos are more likely than NHW to be diagnosed at a distant
stage of disease (58 vs. 54 %) [1], with higher pathologic
stage, they are less likely to receive curative treatment [70].
The molecular status of several tumor (Bdriver^) muta-
tions is often assessed in order to select the most appro-
priate treatment for LC, and successful therapies have
been developed to target EGFR mutations or EML4-
ALK fusions [71]. The prevalence and characteristics of
these driver mutations differ among racial and ethnic
groups [72]. Specifically, whereas KRAS mutations are
predominant in NHW, among Latinos EGFR mutations
are more frequent [71, 73, 74]. Variability in EGFR and
KRAS mutation frequency in NSCLC has been reported
for Latinos from various countries in Latin America, with
the highest frequency observed in Peru, followed by
Costa Rica, Mexico, Panama, Colombia, and Argentina
[72, 73]. Exposure to wood smoke and Mycobacterium
tuberculosis infection have been found to associate with




From 2008 to 2012, rates of liver cancer were 19.3 per
100,000 in men and 7.2 per 100,000 in women; these rates
are higher than NHW and AA, but lower than Asians and IA
[59•]. While the rates of most cancers in Latino populations
are declining, the rate of hepatocellular carcinoma (HCC), the
most common type of liver cancer, is increasing [75]. In
1999–2001, the liver cancer mortality rates among US-born
Latino men were more than twice as high than those for
foreign-born Latino men in California and 65 % higher in
Texas [76]. In California, between 1988 and 2004, US-born
Latino men in California had 86 % higher incidence rates than
foreign-born Latino men [77]. In a recent study in the MEC,
the HCC incidence rate (per 100,000) was almost twice as
high in US-born as in foreign-born Latino men (44.7 vs.
23.1), but comparable and much lower in women (14.5 vs.
13.4) [78]. Two other studies showed higher incidence rates
among Latino men in Florida compared to the incidence rates
in their country of origin [6•] and higher rates in US mainland
than island Puerto Rican men, but not in women [24]. Within
the Latino subpopulation in Florida, Puerto Ricanmen had the
highest incidence rate compared to the Mexicans and Cubans
[6•]. In California, foreign-born Latinos had lower incidence
rates than US-born Latinos, and those living in low SES and
high enclave neighborhoods had higher incidence rates than
their counterparts [77]. However, it was noted that nativity
seemed to be a more important risk determinant than type of
neighborhood.
Risk Factors
Known risk factors for HCC include chronic hepatitis B
(HBV) and hepatitis C (HCV) infection, aflatoxin exposure,
excessive alcohol consumption, obesity, diabetes, cirrhosis of
any etiology, and smoking. Coffee drinking has been associ-
ated with lower HCC incidence [79]. Among Latinos, studies
have suggested that HCV and diabetes are the strongest risk
factors for HCC [78]. It has been shown that eliminating dia-
betes could potentially reduce HCC incidence in all ethnic/
racial groups, with the largest potential for reduction in
Latinos [80]. Another important emerging risk factor that
has been associated with HCC incidence is non-alcoholic fatty
liver disease [81].
A greater prevalence of HCC risk factors among the more
acculturated US-born Latinos is likely to explain the disparity
in HCC incidence by nativity [76]. Acculturation has been
associated with increased rates of smoking, alcohol drinking,
and obesity in Latinos [82, 83]. In the MEC, US-born Latinos
had higher rates of smoking, alcohol drinking, and obesity
compared to foreign-born Latinos. The diverging nativity pat-
terns by sex for HCC might be due to a stronger tendency of
men to adopt unhealthy lifestyles (e.g., excessive alcohol
drinking, weight gain, and illicit drug use) compared with
women [6•]. In the MEC, the difference in the prevalence of
HBV/HCV and diabetes between US-born and foreign-born
Latinos is larger in men than in women [78]. Thus, the greater
difference in prevalence of these factors between the US- and
foreign-born Latino men than women could partially explain
the observed HCC incidence difference in men, but not in
women, between the two nativity groups. US-born Latinos
in California were reported to have higher prevalence of binge
drinking than foreign-born Latinos (California Health
Interview Survey, CHIS). However, even after accounting
for differences in known risk factors, the risk of HCC among
US-born Latinos remained significantly higher compared to
the risk among foreign-born Latinos [78], suggesting that fu-
ture studies are warranted to identify additional risk factors
that contribute to the elevated HCC incidence in US-born
Latinos.
HCV is more common among Puerto Ricans than other
Latino groups [84], whereas heavy alcohol drinking is more
common in Mexican and Puerto Rican men [85], which could
contribute to the observed differences in HCC incidence rates
across subgroups. Finally, exposure to aflatoxins, mycotoxins
and known liver carcinogens present in moldy foodstuffs,
might play a role in Mexican and Central American Latinos
[86].
Clinical Characteristics and Survival
At the time of diagnosis, Latinos are more likely to be diag-
nosed at a localized stage compared with other ethnic/racial
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groups [87]. Despite the low disease stage, Latinos were 25 %
less likely to receive local ablation or surgical resection com-
pared to NHW; less access to care, lower SES, as well as
language/cultural barriers were thought to contribute to this
difference in treatment [88]. HCC is one of the most fatal
cancers; the 5-year survival rate among Latinos is 19 % for
both men and women [89]. Between 1987 and 2001, Latinos
were shown to have lower survival relative to NHW [87].
Receipt of therapy, stage of HCC, year of diagnosis, and other
demographics, however, did not explain the increased mortal-
ity risk among Latinos. Further research is needed to under-
stand if tumor characteristics and prognosis differs by ances-
try, birth location and socioeconomic factors.
Cancer Research in Latinos: Public Health
and Clinical and Translational Impact
Despite immense diversity within the US Latino community
in terms of nativity, genetic ancestry, and degree of accultur-
ation, epidemiological studies tend to consider US Latinos as
one single group. The emerging evidence for some of the
major cancer types (breast, colorectal, prostate, lung, and liv-
er) highlights patterns observed across Latino subpopulations
defined by various indicators of heterogeneity. US-born
Latinos have higher cancer incidence than foreign-born
Latinos. Puerto Rican and Cuban Latinos have higher inci-
dence rates than Mexican Latinos. Opposite to other racial
groups, Latinos living in low SES neighborhoods tend to have
lower incidence rates than those living in higher SES, and for
some cancers (breast), lower incidence rates are also seen in
high Latino enclave neighborhoods. Foreign-born Latinos
tend to have better survival compared to US-born Latinos.
Overall, the emerging picture is that lifestyle and behavioral
factors preserved or fostered among Latino immigrants can
lower cancer risk. One study investigating the role of genetic
ancestry in breast cancer suggested that genetic variants of IA
originmight lower cancer risk, highlighting the possibility that
this could be true for other cancers. We summarize below the
understudied themes that emerge as more pressing to advance
our knowledge of cancer in Latinos and reduce their cancer
burden.
Understanding Risk Profiles and Developing Prediction
Models
There is a dearth of knowledge about risk factors specific for
Latinos and their variability across Latino subpopulations.
Given that by the year 2050, close to 1 in 4 people in the
USA will be Latino, it is critical that we identify the main
cancer determinants in this population. The observed dispar-
ities across subpopulations, and the fact that Latinos are a
population in transition, offer a tremendous opportunity to
identify risk factors and reduce future disease rates. For pre-
vention strategies to be successful, they will need to be cultur-
ally appropriate, as determinants of compliance with preven-
tive strategies might differ from those established for other US
racial/ethnic groups.
There is emerging interest on the potential value of genetic
risk profiling for screening for selected cancer sites, namely
breast and colorectal. Many of the GWAS loci identified in
NHW and Asians appear to generalize to Latinos, although
some studies indicate that there may be Bbetter^ markers for
those genetic regions or other SNPs that may prove more
informative. Existing risk predictive models, such as the wide-
ly used Gail model for breast cancer risk, have been system-
atically used in Latinas. However, it is likely that prediction
would improve if models were developed specifically in
Latina populations and not just generalized from those devel-
oped in NHW populations. Understanding these potential
ethnic/racial differences is pressing.
Tailored Treatment, Reducing Disparities and Improving
Prognosis
Albeit scarce, data is emerging that Latinos may harbor tumor
somatic mutations with different prevalence than other racial
groups. Given that cancer treatments are moving towards the
goal of personalized medicine, understanding the tumor land-
scape of Latinos will be essential to identify the most adequate
therapies. In these studies, it will be imperative to account for
genetic ancestry, and scientific successes in doing so are al-
ready apparent. For example, higher IA ancestry is associated
with Acute Lymphoblastic Leukemia (ALL) relapse among
Latino children, even after adjustment for prognostic factors
[90•]. ALL is the most common type of cancer in children and
disproportionally affects Latinos [91, 92], who have worse
treatment outcome than NHW [92–94]. Higher prevalence
of germline variants in the GATA3 gene are linked to higher
risk of relapse among Latino children [95]. Incorporation of an
additional phase of chemotherapy among patients with high
IA ancestry drastically reduced the disparity in prognosis
[90•]. Given that IA or African ancestry in Latinos also corre-
lates with SES and sociocultural factors, which can also affect
prognosis (e.g., patterns and quality of care) [92], both genetic
and non-genetic heterogeneity are likely to contribute to ALL
outcomes in Latinos and should be considered jointly. A sim-
ilar scenario may apply to other cancers and deserves further
investigation.
Conclusions
Variability in genetic ancestry, exposures, cultural values
brought or inherited from the countries of origin, and the de-
gree of assimilation to US lifestyle are major contributors of
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heterogeneity among Latinos. This heterogeneity has an im-
pact on cancer risk, tumor characteristics, and outcomes. As the
focus on Latino cancer research increases, elucidating the com-
plex interactions between the different sources of heterogeneity
in this understudied population will be critical in order to guide
primary prevention, diagnosis, and treatment strategies tailored
for Latinos. To do so, improving the completeness of country
of origin data in cancer registries will be essential. For this to
happen, it will be important to collect more detailed informa-
tion on Latino subpopulations on hospital admission records at
the time of diagnosis. Moreover, it would help if funding agen-
cies also requested more detailed classification of Latinos than
simply obtaining a single ethnic category. This will help em-
phasize to the public health and research community the need
to address heterogeneity within Latino subpopulations with
respect to disease risk and outcomes.
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